Use of PRF as an alternative treatment for osteonecrosis due to bisphosphonates. First impressions

Article Sidebar

PDF (Español (España))

Downloads

Download data is not yet available.
Published: Oct 19, 2018

DOI: https://doi.org/10.18272/oi.v4i2.1283
Issue
Vol. 4 No. 2 (2018)
Section
Artículos Rehabilitación Oral

Main Article Content

Juan Diego Salazar
Patricio Unda
Andrés Ortiz
Fernando Sandoval Portilla

Abstract

Bisphosphonate-related osteonecrosis of the jaw is a complication that occurs in patients usually undergoing or not to a surgical procedure, who are under treatment or have been previously treated with antiresorptive drugs. The management of this pathology is still controversial, and its treatment is base done alleviating the patient´s symptoms. At present, promising results have been obtained with the use of platelet-rich fibrin (PRF) which stimulates and accelerates tissue regeneration. In this article we present two clinical cases in which favorable results were obtained, presenting at four weeks a total closure of the defects, without the presence of recurrences at six months and a year, as in other reports, suggesting that the use of PRF in the use of this pathology could be an effective alternative, although a greater number of studies is required to demonstrate its effectiveness.

Article Details

How to Cite
Salazar, J. D., Unda, P., Ortiz, A., & Sandoval Portilla, F. (2018). Use of PRF as an alternative treatment for osteonecrosis due to bisphosphonates. First impressions. OdontoInvestigación, 4(2). https://doi.org/10.18272/oi.v4i2.1283

References

Migliario, M., Mergoni, G., Vescovi, P., De Martino, I., Alessio, M., Benzi, L., Renó, F., Fusco, V. Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition. Dentistry Journal. 2017; 5(1): 1-12.

Burcin, Z., Yilmaz, C. Treatment of bisphosphonate-related osteonecrosis of the jaw using platelet-rich fibrin. The journal of craniomandibular & sleep practice. 2016; 35(5): 332-336.

Calvani, F., Cutone, A., Stefania, M., Rosa, L., Valentini, V., Valenti, P. Efficacy of bovine lactoferrin in the post-surgical treatment of patients suffering from bisphosphonate-related osteonecrosis of the jaws: an open-label study. BioMetals. 2018; 1(1): 1-11.

Jeong, H., Hwang, J., Lee, J., Hyun, Y., Yeon, J., Han, S. Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates. Imaging Science in Dentistry. 2017; 47(1): 45-50.

Cano, J., Peña, J., Ortega, D., Paredes, V., Garcia, M., Lopez, J. The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ). Journal of clinical and experimental dentistry. 2017; 9(8): e1051-e1059.

Kim, J., Kim, S., Kim, M. Leucocyte-rich and platelet-rich fibrin for the treatment ofbisphosphonate-related osteonecrosis of the jaw: aprospective feasibility study. British journal of oral and maxillofacial surgery. 2014; 52(9): 854-859.

Ibrahim, V., Dowling, H. Platelet-Rich Plasma as a Nonsurgical Treatment Option for Osteonecrosis. American Academy of Physical Medicine and Rehabilitation. 2012; 4(12): 1015-1019.

Sigua, E., da Costa, R., de Brito, A., Alvarez, N., de Albergia, J. Bisphosphonate-related osteonecrosis of the jaw: a review of the literature. International journal of dentistry. 2014; 2014(1): 1-6.

Ruggiero, S., Dodson, T., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., O´Raya, F. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. Journal of oral and maxillofacial surgery. 2014; 72(10): 1938-1956.

Norholt, S., Hartlev, J. Surgical treatment of osteonecrosis of the jaw with osteonecrosis of the jaw with the use of platelet-rich fibrin: a prospective study of 15 patients. Journal of oral and maxillofacial surgery. 2016; 45(10): 1256-1260.

Atanes, P., Atanes, A., Rios, P., Atanes, D. Osteonecrosis de los maxilares relacionada con el tratamiento con bifosfonatos. Medicina de familia SEMERGEN. 2014; 40(3): 143-148.

Sinen S,US. Management of Bisphosphonate-Related Osteonecrosis of the Jaw with a Platelet-Rich Fibrin Membrane: Technical Report. Journal of oral and maxillofacial surgery. 2014; 72(2): 322-326.

Dinca, O., Zurac, F., Estaniceanu, F., Bogdan, M., Bodnar, D., Vladan, C., Bucur, A. Clinical and histopathological studies using fibrin-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw. Romanian journal of morphology and embryology. 2014; 55(3): 961-964.

He, L., Lyn, Y., Hu, X., Zhang, Y., Wu, H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2009; 108(5): 707-713.

Del Fabbro M,GG,MM. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature. European journal of cancer. 2014; 51(1): 62-74.

Most read articles by the same author(s)